Sacubitril/valsartan in real-life European patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis.

Stefano GiovinazzoLuca CarmiscianoMatteo TomaStefano BenenatiDaniela TomasoniMaria Pia SormaniItalo PortoMarco CanepaMichele SenniMarco MetraPietro Ameri

Published in: ESC heart failure (2021)

Limited-quality RWE indicates that there are important differences between European patients prescribed sacubitril-valsartan and the PARADIGM-HF population, including the frequency of target dose achievement.

Keyphrases

ejection fraction
end stage renal disease
newly diagnosed
chronic kidney disease
patient reported outcomes
atrial fibrillation